There are 1 companies tagged `clinical-stage`; raised $154M from 28 investors
Biolex Therapeutics raised $154M from Dow Venture Capital, Johnson & Johnson Development Corporation, Clarus Ventures, Quaker BioVentures, Bioventures Investors, J.P. Morgan Securities Inc., InterSouth Partners, OrbiMed Advisors, L.L.C., Dogwood Equity, Investor Growth Capital, Mitsui Ventures, Investor Growth Capital, JP Morgan, Easton Capital, Quaker BioVentures, Polaris Partners, InterSouth Partners, Mitsui Ventures, Johnson & Johnson Development, Dow Venture Capital, Polaris Partners, InterSouth Partners, Quaker BioVentures, Johnson & Johnson Development Corporation, Mitsui Ventures, Kitty Hawk Capital, and Johnson & Johnson Development Corporation in 5 rounds.
Biolex Gets $20M From Insiders, Sees Strong Data From Hepatitis C Drug 
fis.dowjones.com
Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron® in Hepatitis C 
mitsuiventures.com
BIOLEX THERAPEUTICS RAISES $30 MILLION TO ADVANCE ITS HEPATITIS C DRUG CANDIDATE AND OTHER PIPELINE PROGRAMS 
biolex.com
BIOLEX THERAPEUTICS RAISES $36 MILLION IN VENTURE FINANCING biolex.com